Increased L-[1- 11C] Leucine Uptake in the Leptomeningeal Angioma of Sturge-Weber Syndrome: A PET Study

Journal of Neuroimaging

Volumn 22, Issue 2, 2012, Pages 177-183

  Alkonyi, Bálint ^a   Chugani, Harry T ^a   Muzik, Otto ^a   Chugani, Diane C ^a   Sundaram, Senthil K ^a   Kupsky, William J ^a   Batista, Carlos E ^a   Juhász, Csaba ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glucose metabolism; Leucine; Positron emission tomography; Proliferation; Sturge Weber syndrome

Indexed keywords

CARBON 11; FLUORODEOXYGLUCOSE F 18; LEUCINE; VASCULOTROPIN A;

ADOLESCENT; AMINO ACID TRANSPORT; ARTICLE; BRAIN REGION; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FRONTAL CORTEX; GLUCOSE METABOLISM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MALE; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PROTEIN SYNTHESIS; SCHOOL CHILD; STURGE WEBER SYNDROME; TUMOR LOCALIZATION;

ADOLESCENT; BRAIN; CHILD; CHILD, PRESCHOOL; FEMALE; HEMANGIOMA; HUMANS; INFANT; LEUCINE; MALE; MENINGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; STURGE-WEBER SYNDROME;

EID: 84859719474     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2010.00565.x     Document Type: Article

References (33)

1. Bentson JR, Wilson GH, Newton TH. Cerebral venous drainage pattern of the Sturge-Weber syndrome. Radiology 1971;101:111-118.
2. Lin DD, Barker PB, Hatfield LA, et al. Dynamic MR perfusion and proton MR spectroscopic imaging in Sturge-Weber syndrome: correlation with neurological symptoms. J Magn Reson Imaging 2006;24:274-281.
3. Roach E, Bodensteiner J. Neurologic manifestations of Sturge-Weber syndrome. In: Bodensteiner JB, Roach ES, eds. Sturge-Weber Syndrome. Mt. Freedom, NJ: The Sturge-Weber Foundation, 1999:27-38.
4. Comi AM. Pathophysiology of Sturge-Weber syndrome. J Child Neurol 2003;18:509-516.
5. Comati A, Beck H, Halliday W, et al. Upregulation of hypoxia-inducible factor (HIF)-1α and HIF-2α in leptomeningeal vascular malformations of Sturge-Weber syndrome. J Neuropathol Exp Neurol 2007;66:86-97.
6. Batista C, Kupsky W, Chugani D, et al. Endothelial cell proliferation and angiogenesis in Sturge-Weber syndrome. Ann Neurol 2008;64(Suppl 12):119-120 [abstract.
7. Norman MG, Schoene WC. The ultrastructure of Sturge-Weber disease. Acta Neuropathol 1977;37:199-205.
8. Juhász C, Haacke EM, Hu J, et al. Multimodality imaging of cortical and white matter abnormalities in Sturge-Weber syndrome. AJNR Am J Neuroradiol 2007;28:900-906.
9. Barwick T, Bencherif B, Mountz JM, et al. Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation. Nucl Med Commun 2009;30:908-917.
10. Plathow C, Weber WA. Tumor cell metabolism imaging. J Nucl Med 2008;49(Suppl 2):43S-63S.
11. Giammarile F, Cinotti LE, Jouvet A, et al. High and low grade oligodendrogliomas (ODG): correlation of amino-acid and glucose uptakes using PET and histological classifications. J Neurooncol 2004;68:263-274.
12. 11C-choline positron-emission tomography. AJNR Am J Neuroradiol 2008;29:1176-1182.
13. 11C]leucine and PET in conscious, young adult men: normal values, variability, and reproducibility. J Cereb Blood Flow Metab 2008;28:1502-1513.
14. 11C]-leucine PET: incorporation of factors for large neutral amino acids in plasma and for amino acids recycled from tissue. J Nucl Med 2006;47:1787-1795.
15. Juhász C, Batista CE, Chugani DC, et al. Evolution of cortical metabolic abnormalities and their clinical correlates in Sturge-Weber syndrome. Eur J Paediatr Neurol 2007;11:277-284.
16. Lee JS, Asano E, Muzik O, et al. Sturge-Weber syndrome: correlation between clinical course and FDG PET findings. Neurology 2001;57:189-195.
17. 11C]leucine as a PET radiotracer for the measurement of cerebral protein synthesis. J Labelled Compds Radiopharm 2005;48:S189.
18. Cizek J, Herholz K, Vollmar S, et al. Fast and robust registration of PET and MR images of human brain. Neuroimage 2004;22:434-442.
19. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7.
20. Hovda DA, Villablanca JR, Chugani HT, et al. Metabolic maturation of the brain: a study of local cerebral protein synthesis in the developing cat. Brain Res 2006;1113:54-63.
21. Batista CE, Juhász C, Muzik O, et al. Imaging correlates of differential expression of indoleamine 2, 3-dioxygenase in human brain tumors. Mol Imaging Biol 2009;11:460-466.
22. Chugani HT, Mazziotta JC, Phelps ME. Sturge-Weber syndrome: a study of cerebral glucose utilization with positron emission tomography. J Pediatr 1989;114:244-253.
23. Di Trapani G, Di Rocco C, Abbamondi AL, et al. Light microscopy and ultrastructural studies of Sturge-Weber disease. Childs Brain 1982;9:23-36.
24. Cunha e Sa M, Barroso CP, Caldas MC, et al. Innervation pattern of malformative cortical vessels in Sturge-Weber disease: an histochemical, immunohistochemical, and ultrastructural study. Neurosurgery 1997;41:872-876; discussion 876-877.
25. 11C-methionine positron emission tomography findings in Sturge-Weber syndrome-case report. Neurol Med Chir (Tokyo) 2003;43:461-464.
26. 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Imaging Biol 2008;10:1-18.
27. Dethy S, Manto M, Kentos A, et al. PET findings in a brain abscess associated with a silent atrial septal defect. Clin Neurol Neurosurg 1995;97:349-353.
28. 11C]methyl-L-tryptophan in human brain tumors. J Cereb Blood Flow Metab 2006;26:345-357.
29. 11C]methionine and rubidium-82 using PET. J Neurol Sci 1995;132:20-27.
30. 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat. Eur J Nucl Med Mol Imaging 2006;33:673-682.
31. Torp SH, Alsaker M. Ki-67 immunoreactivity, basic fibroblastic growth factor (bFGF) expression, and microvessel density as supplementary prognostic tools in low-grade astrocytomas. An immunohistochemical study with special reference to the reliability of different Ki-67 antibodies. Pathol Res Pract 2002;198:261-265.
32. Maton B, Krsek P, Jayakar P, et al. Medically intractable epilepsy in Sturge-Weber syndrome is associated with cortical malformation: implications for surgical therapy. Epilepsia 2010;51:257-267.
33. Sasaki M, Kuwabara Y, Yoshida T, et al. Carbon-11-methionine PET in focal cortical dysplasia: a comparison with fluorine-18-FDG PET and technetium-99m-ECD SPECT. J Nucl Med 1998;39:974-977.